Endometriosis. Portuguese try to speed up diagnosis

A woman experienced persistent pain that was initially dismissed as normal, leading to a long diagnostic journey before receiving a diagnosis of endometriosis at age 23. The article details the progression of symptoms, including vomiting with pain, fever, missed classes, and inability to stand, which lasted nearly twelve years before confirmation of endometriosis. Many women in Portugal report experiencing similar symptom devaluation and inconclusive testing for years. Subsequent medical evaluations involved MRI, ultrasound, colonoscopy, and CT scans to evaluate various systems. A surgical procedure involving bowel resection was performed, followed by two stable years of monitoring. This experience spurred the creation of SENSOPAD, a European project aimed at reducing the eight-year average diagnosis time for endometriosis to months. The project involves developing a technology using a hygienic pad for early inflammation detection and a diagnostic system in Portugal focused on detecting genetic mutations associated with the disease. Researchers are utilizing microfluidics to analyze menstrual blood, separating unwanted components to extract DNA for mutation testing.

The narrative of the endometriosis experience highlights a profound disconnect between lived bodily reality and medical recognition, rooted in decades of symptom devaluation by medical professionals and family. The pursuit of diagnosis was protracted not just due to biological complexity but also because the symptoms were framed as "normal," creating a cycle where personal suffering was invalidated before objective evidence could be fully established. This delay feeds into significant secondary consequences, demonstrated by Susana's experience of infertility, hysterectomy, and lifelong emotional conditioning related to the disease, which itself is often obscured by diagnostic delays. The move toward biomarker detection through novel technologies reflects a tension between the slow, often subjective process of medical validation and the potential for rapid, objective scientific insight into complex, systemic conditions. The focus on microfluidics and genetic analysis suggests an attempt to shift the paradigm from symptom management to root-cause detection, which forces a confrontation with societal taboos surrounding menstrual health and bodily autonomy. The system's success hinges not only on technical precision but also on overcoming institutional inertia and cultural resistance to acknowledging invisible suffering.